Meeder Asset Management Inc Matinas Bio Pharma Holdings, Inc. Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 02, 2018	SELL	$0.35 - $0.92 $781 - $2,054	-2,233 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$0.42 - $0.74 $146 - $258	349 Added 18.52%	2,233 $0
Q1 2018 May 03, 2018	SELL	$0.76 - $1.32 $114 - $199	-151 Reduced 7.42%	1,884 $1,000
Q4 2017 Feb 02, 2018	BUY	$1.1 - $1.54 $264 - $369	240 Added 13.37%	2,035 $2,000
Q3 2017 Oct 20, 2017	BUY	$1.19 - $1.43 $2,136 - $2,566	1,795	1,795 $2,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.